All these data illustrate that autophagy has a protective function against the afatinib-triggered cytotoxicity and apoptosis, and autophagy inhibition can improve the anti-cancer effect of afatinib in lung adenocarcinoma cells with activating EGFR mutations. This evidence concerns the gene EGFR and cancer.